# HFN Versus NIV in Cystic Fibrosis. The HIFEN Study

> **NCT02262871** · NA · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 15 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DEVICE:** High flow nasal oxygen cannula
- **DEVICE:** Noninvasive ventilation

## Key facts

- **NCT ID:** NCT02262871
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-07-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262871, "HFN Versus NIV in Cystic Fibrosis. The HIFEN Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02262871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*